And also carried by prnewswire.com: https://www
Post# of 145836
https://www.prnewswire.com/news-releases/a-pr...63687.html
On another note, AstraZenaca with Oxford UK get $1.2B... unsure if it will work/safe...
why not CytoDyn / Leronlimab which we already know works and is safe...
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)